Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effect of lipid-lowering treatment on indices of MASLD in familial hypercholesterolemia patients.
Boutari C, Rizos CV, Liamis G, Skoumas I, Rallidis L, Garoufi A, Kolovou G, Sfikas G, Tziomalos K, Skalidis E, Kotsis V, Doumas M, Stamatelopoulos K, Lambadiari V, Anagnostis P, Boufidou A, Giannakopoulou V, Anastasiou G, Petkou E, Vlachopoulos C, Dima I, Fakas G, Papathanasiou KA, Attilakos A, Kolovou V, Koumaras C, Agapakis D, Zacharis E, Antza C, Milionis H, Liberopoulos E, Mantzoros CS. Boutari C, et al. Among authors: kolovou v. Clin Nutr. 2024 Oct 16;43(12):84-91. doi: 10.1016/j.clnu.2024.10.020. Online ahead of print. Clin Nutr. 2024. PMID: 39437569
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study.
European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (EAS FHSC). European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (EAS FHSC). Lancet Diabetes Endocrinol. 2024 Nov;12(11):811-823. doi: 10.1016/S2213-8587(24)00221-3. Epub 2024 Oct 4. Lancet Diabetes Endocrinol. 2024. PMID: 39374602 Free article.
Physical signs and atherosclerotic cardiovascular disease in familial hypercholesterolemia: the HELLAS-FH Registry.
Rallidis LS, Rizos CV, Papathanasiou KA, Liamis G, Skoumas I, Garoufi A, Kolovou G, Tziomalos K, Skalidis E, Kotsis V, Sfikas G, Doumas M, Anagnostis P, Lambadiari V, Giannakopoulou V, Kiouri E, Anastasiou G, Petkou E, Koutagiar I, Attilakos A, Kolovou V, Zacharis E, Antza C, Koumaras C, Boutari C, Liberopoulos E. Rallidis LS, et al. Among authors: kolovou v. J Cardiovasc Med (Hagerstown). 2024 May 1;25(5):370-378. doi: 10.2459/JCM.0000000000001612. Epub 2024 Mar 19. J Cardiovasc Med (Hagerstown). 2024. PMID: 38526957
Obesity and atherosclerotic cardiovascular disease in adults with heterozygous familial hypercholesterolemia: An analysis from HELLAS-FH registry.
Barkas F, Rizos CV, Liamis G, Skoumas I, Garoufi A, Rallidis L, Kolovou G, Tziomalos K, Skalidis E, Sfikas G, Kotsis V, Doumas M, Anagnostis P, Lambadiari V, Anastasiou G, Koutagiar I, Attilakos A, Kiouri E, Kolovou V, Polychronopoulos G, Koutsogianni AD, Zacharis E, Koumaras C, Antza C, Boutari C, Liberopoulos E. Barkas F, et al. Among authors: kolovou v. J Clin Lipidol. 2024 May-Jun;18(3):e394-e402. doi: 10.1016/j.jacl.2024.01.005. Epub 2024 Jan 24. J Clin Lipidol. 2024. PMID: 38331687
Familial Hypercholesterolemia in the Elderly: An Analysis of Clinical Profile and Atherosclerotic Cardiovascular Disease Burden from the Hellas-FH Registry.
Antza C, Rizos CV, Kotsis V, Liamis G, Skoumas I, Rallidis L, Garoufi A, Kolovou G, Tziomalos K, Skalidis E, Sfikas G, Doumas M, Lambadiari V, Anagnostis P, Stamatelopoulos K, Anastasiou G, Koutagiar I, Kiouri E, Kolovou V, Polychronopoulos G, Zacharis E, Koumaras C, Boutari C, Milionis H, Liberopoulos E. Antza C, et al. Among authors: kolovou v. Biomedicines. 2024 Jan 19;12(1):231. doi: 10.3390/biomedicines12010231. Biomedicines. 2024. PMID: 38275402 Free PMC article.
Prevalence of Diabetes and Its Association with Atherosclerotic Cardiovascular Disease Risk in Patients with Familial Hypercholesterolemia: An Analysis from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
Boutari C, Rizos CV, Doumas M, Liamis G, Skoumas I, Rallidis L, Garoufi A, Kolovou G, Tziomalos K, Skalidis E, Kotsis V, Sfikas G, Lambadiari V, Anagnostis P, Bilianou E, Anastasiou G, Koutagiar I, Kiouri E, Attilakos A, Kolovou V, Zacharis E, Antza C, Liberopoulos E. Boutari C, et al. Among authors: kolovou v. Pharmaceuticals (Basel). 2022 Dec 28;16(1):44. doi: 10.3390/ph16010044. Pharmaceuticals (Basel). 2022. PMID: 36678541 Free PMC article.
64 results